LATEST TECHNOLOGY

IBM announced the availability of an electronic pedigree system (ePedigree), which will allow pharmaceutical companies to create an electronic certificate of authenticity for every drug, which passes through the supply chain. The ePedigree allows all participants in the drug supply chain, including manufacturers, distributors, pharmacies and hospitals to access historical data on medicine package.

The ePedigree is a new version of IBM’s WebSphere RFID Information Center (RFIDIC), a high performance data repository, which allows users to efficiently manage and securely share information with trading partners to authenticate pharmaceuticals. IBM’s ePedigree uses radio-frequency identification (RFID) tags, which tracks packages of drugs. The new ePedigree offers a flexible ‘track and trace’ framework through standards-based EPC Information Services. Clients would be able to easily access key data elements to solve their business needs like chargeback resolution by generating EPCIS events and queries.

IBM has integrated the Coral8 Engine, complex event processing software from Coral8with ePedigree, which allows customers to set up rules for supply chains. Additionally the ePedigree, is fully compatible with the EPCglobal Electronic Product Code Information Services (EPCIS) standard. The product also integrates the customer master data systems to provide additional business context by using product, location and supplier information.

According to Chris Clauss, director of sensor information management at IBM Software, the whole system watches and keeps records of medicine history. This system is helpful tool for industry to comply with mandates and various trading requirements...LINK